An Octreotide scan with Single-Photon Emission Computed Tomography (SPECT) is a diagnostic imaging procedure used to detect and localize tumors, especially neuroendocrine tumors that produce excessive amounts of certain hormones. Octreotide is a synthetic analogue of somatostatin, which naturally occurs in the body and binds to specific receptors on the surface of these tumors. The patient receives an injection of octreotide, followed by an administration of a radioactive tracer that also binds to these receptors. SPECT technology then captures the distribution of this tracer within the body, providing detailed images of the areas of interest.
An Octreotide scan with Single-Photon Emission Computed Tomography (SPECT) is a diagnostic imaging procedure used to detect and localize tumors, especially neuroendocrine tumors that produce excessive amounts of certain hormones. Octreotide is a synthetic analogue of somatostatin, which naturally occurs in the body and binds to specific receptors on the surface of these tumors. The patient receives an injection of octreotide, followed by an administration of a radioactive tracer that also binds to these receptors. SPECT technology then captures the distribution of this tracer within the body, providing detailed images of the areas of interest.